时间/Date | 类型/Type | 题目/Topic | 讲者/Speaker | 单位/Institution | ||
---|---|---|---|---|---|---|
12:10-12:15 | 致辞 |
开场致辞 |
|
|||
12:15-12:40 | 企业专题 |
引领食代,共鉴胃来: 上消化道肿瘤免疫组化判读现状与反思 |
|
|||
12:40-13:05 | 企业专题 |
前景可期,预后新标尺: 病理缓解评估在肺癌新辅助治疗的应用价值 |
|
|||
13:05-13:10 | 总结 |
总结 |
|
时间/Date | 类型/Type | 题目/Topic | 讲者/Speaker | 单位/Institution | ||
---|---|---|---|---|---|---|
13:10-13:30 | 企业专题 |
Al 在淋巴瘤分子分型应用的探索 |
|
|||
13:30-13:40 | 讨论 |
专家点评 |
|
时间/Date | 类型/Type | 题目/Topic | 讲者/Speaker | 单位/Institution | ||
---|---|---|---|---|---|---|
14:00-14:40 | 专题发言 |
第五版WHO淋巴肿瘤分类的变化介绍 |
|
|||
14:40-15:05 | 专题发言 |
皮肤淋巴瘤研究进展 |
|
|||
15:05-15:30 | 专题发言 |
滤泡辅助T细胞淋巴瘤家族的新命名与鉴别诊断 |
|
|||
15:30-15:38 | 发言交流 |
The immune checkpoint expression in the tumor immune microenvironment of DLBCL: clinicopathologic features and prognosis |
|
|||
15:38-15:46 | 发言交流 |
Epstein−Barr virus-encoded Latent membrane protein 2A (LMP2A) promotes immune escape by upregulating SYK/NF-κB axis in diffuse large B-cell lymphoma (DLBCL) |
|
|||
15:46-15:54 | 发言交流 |
一组血管免疫母细胞性T细胞淋巴瘤继发弥漫大B细胞淋巴瘤病例临床病理学特征分析及探讨 |
|
|||
15:54-16:02 | 发言交流 |
Epstein-Barr Virus-based Prognostic Model to Risk-stratify Patients with Nodular Sclerosis Classic Hodgkin Lymphoma |
|
时间/Date | 类型/Type | 题目/Topic | 讲者/Speaker | 单位/Institution | ||
---|---|---|---|---|---|---|
16:15-16:40 | 专题发言 |
浅谈基层医院病理医师淋巴瘤专科能力提质的实践 |
|
|||
16:40-17:05 | 专题发言 |
IgG4相关性疾病:警钟需长鸣 |
|
|||
17:05-17:13 | 发言交流 |
46例移植后淋巴组织增殖性疾病的临床和病理特点分析 |
|
|||
17:13-17:21 | 发言交流 |
Targeted next generation sequencing reveals recurrent BTG2 E48K mutation in anaplastic diffuse large B-cell lymphoma |
|
|||
17:21-17:29 | 发言交流 |
血管免疫母细胞性T细胞淋巴瘤中CD8+肿瘤浸润淋巴细胞耗竭特点分析 |
|
|||
17:29-17:37 | 发言交流 |
干扰素调节因子8在NK/T细胞性淋巴瘤中表达及临床病理意义的研究 |
|
|||
17:37-17:45 | 发言交流 |
Validation and Interpretation of Lymphoid Disorders with Dual T and B-cell Rearrangement by Using Next-Generation Sequencing-based Clonality Analysis |
|
|||
17:45-17:53 | 发言交流 |
JAK/STAT3 signaling activation related to distinct clinicopathologic features in systemic ALK-negative anaplastic large cell lymphomas: new insights into their heterogeneity |
|